Rocket Pharmaceuticals Inc (NASDAQ:RCKT)
| 15.80 Delayed Data As of 3:59pm ET |  -0.84 / -5.05%Today’s Change | 7.57 Today|||52-Week Range 23.48 | -19.26% Year-to-Date |
Latest RCKT News | Press Releases
No recent news for Rocket Pharmaceuticals Inc.
Today’s Trading
| Previous close | 16.64 |
| Today’s open | 16.70 |
| Day’s range | 15.79 - 16.70 |
| Volume | 36,040 |
| Average volume (3 months) | 919,162 |
| Market cap | $1.3B |
Data as of 3:59pm ET, 03/28/2023
Growth & Valuation
| Earnings growth (last year) | -21.77% |
| Earnings growth (this year) | -3.56% |
| Earnings growth (next 5 years) | +30.28% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.69 |
Competitors
| ---- | ||
| RCUSArcus Biosciences In... | -0.03 | -0.17% |
| DVAXDynavax Technologies... | -0.20 | -2.01% |
| IOVAIovance Biotherapeut... | +0.04 | +0.65% |
Data as of 3:59pm ET, 03/28/2023
Financials
| Next reporting date | May 10, 2023 |
| EPS forecast (this quarter) | -$0.84 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$221.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cranbury, New Jersey |
Forecasts
